Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The biology of Philadelphia chromosome-like ALL.

Best practice & research. Clinical haematology - 1 Sept 2017

Roberts Kathryn G

Abstract excerpt

Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a recently described subtype of B-cell precursor ALL with a gene expression profile similar to Ph-positive ALL and a high frequency of IKZF1 alterations. The prevalence of Ph-like ALL increases with age, ranging from 10-15% of children to over 25% of young adults with ALL. It occurs more frequently in males and is associated with adverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Regulation, Leukemic
Share to Ikaros Transcription Factor
Share to Janus Kinases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Philadelphia Chromosome

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Receptors, Cytokine

Share to STAT Transcription Factors

Share to Transplantation, Homologous

Source

Identifiers

PMID: 29050694
DOI: 10.1016/j.beha.2017.07.003

Genes

ABL1
CRLF2
IKZF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The biology of Philadelphia chromosome-like ALL.PMID 29050694Read ↗

Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Philadelphia chromosome–like acute lymphoblastic leukemiaSemantic proximity Read ↗

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in AdultsSemantic proximity Read ↗

Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?Semantic proximity Read ↗

Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular LandscapeSemantic proximity Read ↗

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.Semantic proximity Read ↗

Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.Semantic proximity Read ↗

Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review articleSemantic proximity Read ↗

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Semantic proximity Read ↗

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.